The United States would be interested in the construction of a manufacturing plant for doses against the coronavirus, in Colombia and Ecuador, according to Colombian media.
The Government of Ecuador outlines a vaccine factory assembly plan in the medium term although without a specific date.
“We are going to work on the legal part. We have already we have an excellent proposal together with INSPI (National Institute for Public Health Research), ESPE (University of the Armed Forces); We are working very quickly on our assembly plan for the vaccine factory and also for biosimiles ”, said the Minister of Health, Ximena Garzón, in a discussion with the media this Wednesday, although he did not give further details about it.
He added that he is working with Roberto Salas, secretary of public-private partnerships, and that when they have the structured project, it will be announced.
Roberto Salas: What we seek is to have an impact from next year
At the beginning of this month, a Colombian media outlet published a story of an alleged interest of the United States Government for the construction of a manufacturing plant for doses against the coronavirus, particularly in Colombia and Ecuador.
This newspaper consulted Garzón on the matter. She replied that the regime is developing the proposal for the construction and implementation of the plant and being a proposal for a public-private relationship are open to countries such as United States, China, Israel, Belgium They can collaborate and the Executive will determine what are the best options for a strategic partner.
“It is still very early to say with this country let’s go hand in hand for this great project … ”, he mentioned.
Ecuador’s general population will receive anti-COVID-19 booster doses from January 2022
Regarding the vaccine Russian Sputnik, The official said that there is no certain information on when it could be imported, but mentioned that there are enough vaccines, more than 9 million in the country, from AstraZeneca, Pfizer, Sinovac, Cansino, and 3 million additional that will arrive between January and February 2022.
Paul is a talented author and journalist with a passion for entertainment and general news. He currently works as a writer at the 247 News Agency, where he has established herself as a respected voice in the industry.
